Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 3 November 2022, 09:00 HKT/SGT
Share:
    

Source: WestCann Holdings Limited
WestCann Commercializes Reconstituted Cannabis
Patented tobacco processing technology expected to be disruptive to the recreational cannabis pre-roll market

Perth, Australia, Vancouver, British Columbia and Greenville, North Carolina, Nov 3, 2022 - (ACN Newswire) - WestCann Holdings Ltd. ("WCH" or the "Company") is pleased to announce that it has signed an agreement with IOTO USA, LLC ("IOTO") for the exclusive global licensing of all uses with cannabis and hemp of IOTO's patented technologies for the reconstitution of plant matter.


Originally developed for the primary processing of tobacco, IOTO's technologies allow for complete homogenization of cannabis as well as for full process control over the active ingredients and smoking characteristics. As a result, precision tobacco cigarette making and packaging equipment can be utilized for pre-roll manufacturing, creating a highly consistent and reproducible consumer product with significant quality and cost advantages.

The Company's wholly owned subsidiary WestCann Processors Inc. is planning to start the manufacturing of reconstituted cannabis pre-rolls for the Canadian recreational market at its Yorkton, SK facility by December 2022 and expects its products to be available to consumers through licensed retail stores in early 2023.

CEO Andreas Gedeon: "I'm convinced that our products will be disruptive to the existing pre-roll market, which is one of the single biggest growing segments in the cannabis industry. I believe that consumers will quickly appreciate our convenient format and the fact that they can always get the same experience with the next pack they purchase, all at a discount to what they are used to paying right now."

The exclusive license to IOTO's technologies complements WestCann's portfolio of custom engineered automatization solutions, including its patented child resistant hinge lid pack that is certified for use in Canada, the U.S., Switzerland and the EU.

Over the course of the next year, the Company plans on partnering with licensed operations in several U.S. states for additional installations of its fully automated pre-roll making and packing lines, as well as on preparing to be a first mover in the upcoming recreational cannabis markets in Germany and Thailand.

For further information please visit www.westcann.com or contact Andreas Gedeon, CEO at andreas@westcann.com.

About WestCann

WestCann Holdings Ltd., based in Perth, WA and its wholly owned subsidiaries WestCann Processors Inc, 102021671 Saskatchewan Inc. in Canada and Laika Brands, LLC in Nevada are focusing on the transfer of tobacco processing technologies to the recreational cannabis markets. For more information on WestCann please visit www.westcann.com.

About IOTO

IOTO USA, LLC, a subsidiary of IOTO International in Brazil, is a global leader in the provision of flavorings and reconstitution technologies for tobacco. For more information on IOTO please visit www.iotointernational.com.

PRESS RELEASE CONTACT
Andreas Gedeon
+1 (250) 713-6302
andreas@westcann.com


Topic: Press release summary
Source: WestCann Holdings Limited

Sectors: Cannabis
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Olympus Appoints New CEO  
Friday, April 25, 2025 9:43:00 PM
Strengthening Hong Kong-Zhejiang ties  
Apr 25, 2025 21:05 HKT/SGT
Graphene Manufacturing Group Provides Quarterly ATM Sales Update  
Apr 25, 2025 20:29 HKT/SGT
Edvantage Group Announces FY2025 Interim Results  
Apr 25, 2025 20:05 HKT/SGT
TIME Interconnect Technology Limited Announces Final Results For The Year Ended 31 December 2024  
Apr 25, 2025 20:03 HKT/SGT
NEC achieves Japan's longest terrestrial wireless optical communication over 10 km  
Friday, April 25, 2025 4:50:00 PM
Coya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with Mild to Moderate Frontotemporal Dementia  
Apr 25, 2025 15:49 HKT/SGT
DENSO Announces Year-End Financial Results  
Friday, April 25, 2025 11:17:00 AM
Mooreast Holdings Announces Business Update  
Apr 25, 2025 10:00 HKT/SGT
HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025  
Apr 24, 2025 18:43 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: